Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-01-20 Sale |
2022-01-24 4:36 pm |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
40,000 | $39.66 | $1,586,500 | 540,992 (Direct) |
View |
| 2022-01-11 Sale |
2022-01-13 4:09 pm |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
14,566 | $48.68 | $709,027 | 431,546 (Direct) |
View |
| 2022-01-11 Sale |
2022-01-13 4:08 pm |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
5,419 | $48.53 | $262,975 | 155,849 (Direct) |
View |
| 2022-01-11 Sale |
2022-01-13 4:07 pm |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
4,570 | $48.5 | $221,655 | 146,532 (Direct) |
View |
| 2022-01-11 Sale |
2022-01-13 4:06 pm |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
1,770 | $48.45 | $85,757 | 108,634 (Direct) |
View |
| 2022-01-11 Sale |
2022-01-13 4:05 pm |
FATE THERAPEUTICS INC | FATE | Chu Yu-Waye Senior VP Clinical Development |
3,965 | $48.51 | $192,340 | 121,793 (Direct) |
View |
| 2022-01-10 Sale |
2022-01-12 4:07 pm |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
34,156 | $46.86 | $1,600,534 | 446,112 (Direct) |
View |
| 2022-01-10 Sale |
2022-01-12 4:06 pm |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
7,738 | $46.43 | $359,313 | 161,268 (Direct) |
View |
| 2022-01-10 Sale |
2022-01-12 4:05 pm |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
5,596 | $46.38 | $259,558 | 151,102 (Direct) |
View |
| 2022-01-03 Sale |
2022-01-04 4:03 pm |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
50,000 | $59.34 | $2,966,853 | 235,649 (Direct) |
View |
| 2021-12-20 Sale |
2021-12-21 4:08 pm |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
15,977 | $60 | $958,620 | 238,642 (Direct) |
View |
| 2021-12-13 Sale |
2021-12-14 4:18 pm |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
25,000 | $47.66 | $1,191,406 | 217,854 (Direct) |
View |
| 2021-12-10 Sale |
2021-12-13 5:53 pm |
FATE THERAPEUTICS INC | FATE | Chu Yu-Waye Senior VP Clinical Development |
7,500 | $51.46 | $385,948 | 230,758 (Direct) |
View |
| 2021-11-18 Sale |
2021-11-22 5:45 pm |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
20,000 | $54.27 | $1,085,400 | 559,714 (Direct) |
View |
| 2021-10-21 Sale |
2021-10-25 4:04 pm |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
60,000 | $59.55 | $3,572,960 | 603,239 (Direct) |
View |
| 2021-10-01 Sale |
2021-10-04 4:12 pm |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
50,000 | $58.83 | $2,941,462 | 224,691 (Direct) |
View |
| 2021-09-28 Sale |
2021-09-30 4:14 pm |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
19,460 | $62.53 | $1,216,834 | 195,079 (Direct) |
View |
| 2021-09-13 Sale |
2021-09-14 4:01 pm |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
25,000 | $66.29 | $1,657,257 | 181,896 (Direct) |
View |
| 2021-08-19 Sale |
2021-08-20 4:02 pm |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
20,000 | $88.01 | $1,760,204 | 398,639 (Direct) |
View |
| 2021-08-19 Sale |
2021-08-20 4:01 pm |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
3,474 | $88.26 | $306,602 | 54,539 (Direct) |
View |
| 2021-07-22 Sale |
2021-07-26 4:05 pm |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
60,000 | $85.67 | $5,140,113 | 608,639 (Direct) |
View |
| 2021-07-01 Sale |
2021-07-02 7:08 pm |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
55,534 | $85.24 | $4,733,743 | 324,634 (Direct) |
View |
| 2021-06-14 Sale |
2021-06-16 4:26 pm |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
25,000 | $89.32 | $2,233,045 | 206,896 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-01-21 Exercise |
2022-01-24 4:36 pm |
N/A 2026-01-11 |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
10,000 | $2.7 | 540,992 (Direct) |
View |
| 2022-01-20 Exercise |
2022-01-24 4:36 pm |
N/A 2027-01-03 |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
30,000 | $2.73 | 540,992 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-04 4:03 pm |
N/A 2028-01-16 |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
50,000 | $0 | 235,649 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-04 4:03 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
50,000 | $6.55 | 235,649 (Direct) |
View |
| 2021-12-20 Exercise |
2021-12-21 4:08 pm |
N/A 2030-08-17 |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
14,437 | $0 | 238,642 (Direct) |
View |
| 2021-12-20 Exercise |
2021-12-21 4:08 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
14,437 | $35.52 | 238,642 (Direct) |
View |
| 2021-12-13 Exercise |
2021-12-14 4:18 pm |
N/A 2027-01-04 |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
25,000 | $0 | 217,854 (Direct) |
View |
| 2021-12-13 Exercise |
2021-12-14 4:18 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
25,000 | $2.73 | 217,854 (Direct) |
View |
| 2021-12-10 Exercise |
2021-12-13 5:53 pm |
N/A 2029-04-15 |
FATE THERAPEUTICS INC | FATE | Chu Yu-Waye Senior VP Clinical Development |
7,500 | $0 | 230,758 (Direct) |
View |
| 2021-12-10 Exercise |
2021-12-13 5:53 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Chu Yu-Waye Senior VP Clinical Development |
7,500 | $16.32 | 230,758 (Direct) |
View |
| 2021-11-18 Exercise |
2021-11-22 5:45 pm |
N/A 2026-01-11 |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
20,000 | $0 | 559,714 (Direct) |
View |
| 2021-11-19 Option Award |
2021-11-22 5:45 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
86,475 | $0 | 559,714 (Direct) |
View |
| 2021-11-18 Exercise |
2021-11-22 5:45 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
20,000 | $2.7 | 559,714 (Direct) |
View |
| 2021-11-19 Option Award |
2021-11-22 5:44 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
60,958 | $0 | 156,698 (Direct) |
View |
| 2021-11-19 Option Award |
2021-11-22 5:43 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
60,958 | $0 | 169,006 (Direct) |
View |
| 2021-11-19 Option Award |
2021-11-22 5:41 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Plavsic Mark Chief Technical Officer |
59,540 | $0 | 97,540 (Direct) |
View |
| 2021-11-19 Option Award |
2021-11-22 5:41 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
59,540 | $0 | 111,944 (Direct) |
View |
| 2021-11-19 Option Award |
2021-11-22 5:38 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Chu Yu-Waye Senior VP Clinical Development |
60,958 | $0 | 125,758 (Direct) |
View |
| 2021-10-21 Exercise |
2021-10-25 4:04 pm |
N/A 2027-01-03 |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
60,000 | $0 | 603,239 (Direct) |
View |
| 2021-10-22 Exercise |
2021-10-25 4:04 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
4,846 | $4.84 | 603,239 (Direct) |
View |
| 2021-10-22 Exercise |
2021-10-25 4:04 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
15,154 | $2.7 | 603,239 (Direct) |
View |
| 2021-10-21 Exercise |
2021-10-25 4:04 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
40,000 | $2.73 | 603,239 (Direct) |
View |
| 2021-10-01 Exercise |
2021-10-04 4:12 pm |
N/A 2028-01-16 |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
50,000 | $0 | 224,691 (Direct) |
View |
| 2021-10-01 Exercise |
2021-10-04 4:12 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
50,000 | $6.55 | 224,691 (Direct) |
View |
| 2021-09-28 Exercise |
2021-09-30 4:14 pm |
N/A 2030-08-17 |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
17,325 | $0 | 195,079 (Direct) |
View |
| 2021-09-28 Exercise |
2021-09-30 4:14 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
17,325 | $35.52 | 195,079 (Direct) |
View |
| 2021-09-13 Exercise |
2021-09-14 4:01 pm |
N/A 2027-01-04 |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
25,000 | $0 | 181,896 (Direct) |
View |
| 2021-09-13 Exercise |
2021-09-14 4:01 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
25,000 | $2.73 | 181,896 (Direct) |
View |
| 2021-08-19 Exercise |
2021-08-20 4:02 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
20,000 | $4.835 | 398,639 (Direct) |
View |
| 2021-08-19 Exercise |
2021-08-20 4:02 pm |
N/A 2025-01-04 |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
20,000 | $0 | 398,639 (Direct) |
View |
| 2021-08-03 Option Award |
2021-08-05 4:04 pm |
N/A 2031-08-02 |
FATE THERAPEUTICS INC | FATE | Xu Yuan Director |
12,245 | $0 | 12,245 (Direct) |
View |
| 2021-07-22 Exercise |
2021-07-26 4:05 pm |
N/A 2027-01-03 |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
60,000 | $0 | 608,639 (Direct) |
View |
| 2021-07-23 Exercise |
2021-07-26 4:05 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
20,000 | $4.84 | 608,639 (Direct) |
View |
| 2021-07-22 Exercise |
2021-07-26 4:05 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
40,000 | $2.73 | 608,639 (Direct) |
View |
| 2021-07-01 Exercise |
2021-07-02 7:08 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
27,685 | $4.89 | 324,634 (Direct) |
View |
| 2021-07-01 Exercise |
2021-07-02 7:08 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
5,534 | $7.87 | 324,634 (Direct) |
View |
| 2021-07-01 Exercise |
2021-07-02 7:08 pm |
N/A 2023-08-12 |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
55,534 | $0 | 324,634 (Direct) |
View |
| 2021-07-01 Exercise |
2021-07-02 7:08 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
15,383 | $6.55 | 324,634 (Direct) |
View |
| 2021-07-01 Exercise |
2021-07-02 7:08 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
6,932 | $4.84 | 324,634 (Direct) |
View |
| 2021-06-14 Option Award |
2021-06-22 4:03 pm |
N/A 2031-06-14 |
FATE THERAPEUTICS INC | FATE | Plavsic Mark Chief Technical Officer |
56,500 | $0 | 56,500 (Direct) |
View |
| 2021-06-14 Exercise |
2021-06-16 4:26 pm |
N/A 2026-01-08 |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
25,000 | $0 | 206,896 (Direct) |
View |
| 2021-06-14 Exercise |
2021-06-16 4:26 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
16,156 | $2.9 | 206,896 (Direct) |
View |
| 2021-06-14 Exercise |
2021-06-16 4:26 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
8,844 | $2.73 | 206,896 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-04 5:33 pm |
N/A 2031-06-01 |
FATE THERAPEUTICS INC | FATE | HERSHBERG ROBERT Director |
7,015 | $0 | 7,015 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-04 5:33 pm |
N/A 2031-06-01 |
FATE THERAPEUTICS INC | FATE | COUGHLIN TIMOTHY Director |
7,015 | $0 | 63,405 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-04 5:30 pm |
N/A 2031-06-01 |
FATE THERAPEUTICS INC | FATE | RASTETTER WILLIAM H Director |
7,015 | $0 | 613,108 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-04 5:29 pm |
N/A 2031-06-01 |
FATE THERAPEUTICS INC | FATE | EPSTEIN ROBERT S Director |
7,015 | $0 | 7,015 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-04 5:27 pm |
N/A 2031-06-01 |
FATE THERAPEUTICS INC | FATE | Jooss Karin Director |
7,015 | $0 | 7,015 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-04 5:26 pm |
N/A 2031-06-01 |
FATE THERAPEUTICS INC | FATE | Agarwal Shefali Director |
7,015 | $0 | 7,015 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-04 5:24 pm |
N/A 2031-06-01 |
FATE THERAPEUTICS INC | FATE | MENDLEIN JOHN Director |
7,015 | $0 | 163,789 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-04 4:07 pm |
N/A 2031-06-02 |
FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director 10% Owner |
7,015 | $0 | 12,964,237 (Indirect) |
View |